hrt
hormone therapy
health
science
Metabolic Health
ovarian health
Female Fertility
longevity
Lab Testing
Wellness
hrt
hormone therapy
health
science
Metabolic Health
ovarian health
Female Fertility
longevity
Lab Testing
Wellness
10 min read

What Is HRT? The Honest Guide to Hormone Replacement Therapy

written by

Healthspan Team

published09 / 07 / 2026
Take Home Points

HRT is not one thing — the hormone, the dose, the delivery method, and when you start all change the risk-benefit equation entirely.

Transdermal estrogen carries significantly less clotting and stroke risk than oral estrogen, and that distinction matters clinically.

The 2002 WHI study scared a generation away from HRT based on findings that don't apply to most of the women who would benefit from it today.

Bioidentical progesterone and synthetic progestins are not interchangeable — formulation is everything when it comes to safety.

HRT is not a wellness trend. It's a targeted medical intervention that works best with real labs, a real clinician, and ongoing monitoring.

For men, low testosterone confirmed by blood work is a clinical condition with effective treatment — not just "part of getting older."

Start with your labs, not a protocol someone recommended on social media.

A few years ago, hormone replacement therapy was the thing doctors quietly steered you away from. One controversial study in the early 2000s scared the medical establishment into near-blanket avoidance of HRT, and millions of people spent years suffering through hot flashes, brain fog, and bone loss because of it. The good news: the science has been re-examined, the pendulum has swung, and the conversation around HRT looks very different today.

So, what is HRT? Hormone replacement therapy is exactly what it sounds like: replacing hormones your body has stopped making in sufficient quantities. That's usually estrogen and progesterone for women navigating perimenopause and menopause, and testosterone for men dealing with age-related hormonal decline. But the picture is more nuanced than a single sentence can capture, and the details matter a lot if you're trying to figure out whether this is right for you.

Here's what we'll cover: the different types of HRT, what conditions they actually treat, what the evidence says (including the parts the internet glosses over), who the ideal candidate is, and how to approach this clinically rather than based on a Reddit thread. Let's get into it.

What Is HRT, Really?

Hormone replacement therapy is a broad term for medical protocols that use hormones, either identical to those your body makes or chemically similar, to compensate for declining hormone levels. The "replacement" framing is important: this isn't about boosting hormones to superhuman levels. It's about restoring them to a range your body once considered normal.

Think of it like topping off a fuel tank that's been slowly draining. Your car doesn't run great on fumes. Neither does your brain, your cardiovascular system, or your bones when key hormones fall below the threshold your biology was designed for.

Historically, HRT referred almost exclusively to estrogen therapy for menopausal women. Today the term is used more broadly to include testosterone replacement for men (sometimes called TRT), progesterone therapy, and combination protocols that address multiple hormones at once.

A Brief Origin Story

The use of hormones in medicine dates back to the 1890s, when crude thyroid extracts were given to patients with hypothyroidism. Synthetic estrogen arrived in the 1940s, and by the 1960s, HRT was being marketed to women almost as aggressively as vitamins. Then came 2002, when the Women's Health Initiative (WHI) published findings suggesting HRT raised risks of breast cancer and heart disease. Prescriptions cratered overnight. What the headlines missed: the study used older women (average age 63) who were more than a decade past menopause, and used oral conjugated equine estrogen combined with synthetic progestins. It didn't represent how most clinicians use HRT today. The subsequent re-analysis, and decades of follow-up research, have significantly refined that picture.

Types of Hormone Replacement Therapy

Not all HRT is the same. The type of hormone, the delivery method, and the specific formulation all change the risk-benefit equation. Here's a breakdown of what's actually available.

Estrogen Therapy

Estrogen is the primary driver of most menopausal symptoms: hot flashes, night sweats, vaginal dryness, sleep disruption, mood instability, and cognitive changes. Replacing it addresses all of these. Estrogen comes in several forms:

  • Transdermal patches: deliver estradiol (the most bioavailable form of estrogen) through the skin, bypassing the liver. This is significant because oral estrogens increase clotting factors in the liver, which transdermal forms largely avoid. Healthspan offers the Estradiol Patch as part of its women's hormone protocols.
  • Topical creams: Bi-Est (a blend of estradiol and estriol) is a compounded option. Healthspan's Bi-Est 50/50 Cream provides both forms of estrogen in a transdermal cream format.
  • Oral estrogen: convenient but associated with higher clotting risk due to first-pass liver metabolism. Less commonly recommended now for systemic use.
  • Vaginal estrogen: low-dose, local delivery for genitourinary symptoms. Minimal systemic absorption, very favorable safety profile.

Progesterone Therapy

If you still have a uterus, you need progesterone alongside estrogen. Unopposed estrogen (estrogen without progesterone) stimulates the uterine lining and increases the risk of endometrial cancer. Progesterone protects against that. But here's where formulation matters enormously: synthetic progestins (like medroxyprogesterone acetate, used in the WHI study) carry risks that bioidentical progesterone does not. Micronized progesterone, which is chemically identical to what your body makes, has a much more favorable profile, including potential benefits for sleep and anxiety. Healthspan's Micronized Progesterone uses this body-identical form.

Testosterone Replacement Therapy (TRT)

Testosterone isn't just a "male" hormone. It plays a role in energy, libido, muscle mass, bone density, and mood in both sexes. For men, testosterone levels decline roughly 1-2% per year after age 30. By the time you're in your 50s, low testosterone (hypogonadism) is common and clinically meaningful. For women, testosterone is produced in smaller amounts but matters for libido, energy, and cognitive function, and it drops during perimenopause and menopause too.

Testosterone therapy for men comes in several delivery formats, each with tradeoffs:

  • Injections: highest bioavailability, can cause peaks and troughs in levels. Healthspan offers Testosterone Cypionate injections.
  • Topical gel: steady daily delivery, lower risk of polycythemia (elevated red blood cell count) than injections. Available as Testosterone Gel at Healthspan.
  • Topical cream: similar to gel, with slightly different absorption characteristics. Healthspan offers Testosterone Topical Cream.

Bioidentical vs. Synthetic Hormones

You'll hear the word "bioidentical" a lot in this space. It means the hormone molecule is structurally identical to what your body produces. Bioidentical estradiol, progesterone, and testosterone are all FDA-approved. The confusion comes from compounded bioidentical hormones, which are custom-mixed at specialty pharmacies. Compounded versions can be valuable for personalized dosing, but they're not FDA-approved for efficacy and safety as finished products. Neither is automatically better. What matters is the specific hormone, the dose, the delivery method, and clinical monitoring.

What Conditions Does HRT Actually Treat?

HRT isn't a wellness supplement. It's a medical intervention for specific, documented hormonal deficiencies. Here's where the evidence is clearest:

Menopause Symptoms

This is the strongest indication for estrogen-based HRT, full stop. Hot flashes, night sweats, sleep disruption, vaginal dryness, and mood instability all respond to estrogen therapy. The evidence base here is enormous and well-replicated. Studies show HRT reduces hot flash frequency by 75-90% compared to placebo. If menopause symptoms are disrupting your quality of life, HRT is not an experimental option. It's a well-supported one.

Bone Density and Osteoporosis Prevention

Estrogen is protective for bone. When it drops at menopause, bone loss accelerates. HRT is one of the most effective tools for preserving bone density, with studies showing it can reduce fracture risk by up to 33%. This is one reason earlier initiation (closer to the onset of menopause) tends to produce better long-term outcomes.

Cardiovascular Risk

This is where the WHI story gets nuanced. The "timing hypothesis" has now been well-studied: women who start HRT within 10 years of menopause onset (or before age 60) appear to have cardiovascular benefits from estrogen. Those who start much later may not. The key mechanism is that estrogen helps maintain arterial flexibility. A 2022 meta-analysis in The Lancet found that transdermal estrogen did not increase clotting risk, unlike oral forms.

Cognitive Function

The relationship between estrogen and brain health is genuinely interesting and not yet fully settled. There's mechanistic evidence that estrogen supports neuronal function, and some observational data linking earlier HRT use to lower dementia risk. But we don't have definitive randomized trial data yet. Promising. Not proven. Worth watching.

Hypogonadism in Men

For men with clinically low testosterone (confirmed by labs, not just symptoms alone), TRT improves energy, libido, body composition, mood, and bone density. A 2023 study in the New England Journal of Medicine found testosterone therapy in men with symptomatic hypogonadism improved sexual function and physical performance without increasing cardiovascular risk. The key qualifier: it needs to be clinically indicated, not just "I want more muscle."

What the Evidence Actually Shows (The Reality Check)

The internet wants HRT to be a fountain of youth. It isn't. It's a targeted medical intervention that works well for specific problems in specific populations when used correctly. Here's what's real, what's overstated, and what's still genuinely unknown.

Real: HRT is highly effective for menopausal symptoms, bone loss prevention, and quality of life in appropriately selected women. For men with true hypogonadism, TRT has solid evidence behind it.

Overstated: The idea that HRT is universally safe with no caveats. Oral estrogen does carry clotting risks. Synthetic progestins carry breast cancer risk signals that bioidentical progesterone may not, but the data isn't perfectly clean. Women with certain conditions, including hormone-receptor-positive breast cancer, active liver disease, or unexplained vaginal bleeding, are not good candidates.

Unknown: The long-term cognitive benefits of HRT. The optimal duration of therapy. The full safety profile of compounded bioidentical hormones at scale. The ideal time to taper versus continue indefinitely. These are active areas of research, and anyone who tells you they have definitive answers is overstating the science.

You are not a clinical trial. The risk-benefit calculation is individual, and it requires your actual labs, your health history, and a clinician who knows what they're looking at.

Who Is HRT Actually Right For?

HRT isn't for everyone, and ruling yourself in or out based on a symptom checklist isn't enough. Here's a more honest picture of who tends to benefit most:

  • Women in perimenopause or early menopause (under 60 or within 10 years of last period) with moderate-to-severe vasomotor symptoms, sleep disruption, or genitourinary symptoms. This is the clearest candidate.
  • Women at elevated risk for osteoporosis, particularly those with family history or early bone density decline, even if symptoms are mild.
  • Men with labs-confirmed low testosterone (total testosterone consistently below 300 ng/dL, with symptoms) who have ruled out reversible causes like poor sleep or obesity.
  • Perimenopausal women with significant mood changes, cognitive symptoms, or low libido, especially when other causes have been excluded.

Who might not be a good fit: women with a history of hormone-receptor-positive breast cancer or blood clotting disorders should have a careful, individualized conversation with a clinician before considering systemic HRT. This isn't a blanket "never," but it requires more scrutiny.

Risks and Side Effects

Honest version: HRT carries real risks, and they depend significantly on what you take, how you take it, and when you start. Here's the overview:

  • Breast cancer: the clearest risk signal is with combined estrogen-progestin therapy using synthetic progestins, particularly beyond 5 years. The absolute risk increase is small but real. Bioidentical progesterone appears to carry less risk, though the data isn't perfect.
  • Blood clots (VTE): oral estrogen increases clotting risk. Transdermal estrogen largely does not. This is one strong argument for patches or creams over pills for systemic use.
  • Stroke: oral estrogen carries a small elevated risk. Transdermal estrogen appears much safer in this regard.
  • For men on TRT: polycythemia (thickened blood from elevated red blood cells), testicular atrophy, infertility, acne, and in some cases elevated estradiol. All of these are manageable with proper monitoring.
  • Testosterone in women: virilization (facial hair, voice changes, clitoral enlargement) at high doses. Appropriate low dosing avoids this.

The through-line: most of these risks are dose-dependent, delivery-method-dependent, and manageable with proper clinical monitoring. The answer to "HRT carries risks" isn't avoidance. It's informed supervision.

How to Get Started With HRT at Healthspan

This is where Healthspan's model makes a real difference. Most people either go to a primary care doctor who's undertrained in hormonal medicine, or they stumble into a wellness clinic that's more interested in selling them things than evaluating whether those things are appropriate. Neither is ideal.

Healthspan's approach starts with labs, not a prescription pad. Before anything is recommended, you'll have baseline hormone levels measured, including estradiol, progesterone, testosterone (total and free), SHBG, and relevant metabolic markers. That baseline tells the clinician what's actually happening, not just what you think is happening based on how you feel.

For women, Healthspan offers multiple HRT options tailored to where you are hormonally and what your goals are. The Women's Hormone Health program is the starting point, covering the clinical consultation, lab review, and protocol design. From there, your protocol might include the Estradiol Patch, Micronized Progesterone, or the Bi-Est 50/50 Cream, depending on your specific hormonal picture and preferences. Follow-up labs and dose adjustments are built into the process.

For men, the Men's Hormone Health program works the same way: labs first, then a clinician-designed protocol that might include Testosterone Cypionate, Testosterone Gel, or Testosterone Topical Cream, with ongoing monitoring of hematocrit, PSA, and hormone levels to keep things in range.

The clinical supervision is what separates a thoughtful protocol from a gamble. If you're ready to find out what your hormones are actually doing and what to do about it, the right first step is a consultation with Healthspan.

Frequently Asked Questions About HRT

What is HRT used for?

HRT is primarily used to treat symptoms of menopause in women, including hot flashes, night sweats, sleep problems, and vaginal dryness. It's also used to prevent bone loss, support cardiovascular health (when started early in menopause), and address low testosterone in men. The specific hormones and delivery methods used depend on your individual hormonal picture and health history.

Is HRT safe?

HRT is considered safe for most healthy women who start it before age 60 or within 10 years of menopause. The risk profile depends heavily on the type of hormone (bioidentical vs. synthetic), delivery method (transdermal vs. oral), and duration of use. Transdermal estrogen carries significantly lower clotting and stroke risk than oral forms. Individualized assessment with current labs is essential to evaluate safety for your specific situation.

What's the difference between bioidentical and synthetic hormones?

Bioidentical hormones are chemically identical to hormones your body produces naturally. Synthetic hormones, like the progestins used in the original WHI study, have a different molecular structure and behave differently in the body. Research suggests bioidentical progesterone carries a more favorable safety profile than synthetic progestins, particularly regarding breast cancer risk. The delivery method and dose matter as much as the type of hormone.

How long does it take for HRT to work?

Most people notice improvement in hot flashes and sleep within 4-6 weeks of starting estrogen therapy. Full benefit, particularly for mood, cognitive clarity, and bone density, may take 3-6 months. Testosterone replacement for men typically shows improvements in energy and libido within 4-8 weeks, with body composition changes taking several months of consistent therapy and monitoring.

Can men use hormone replacement therapy?

Yes. Testosterone replacement therapy (TRT) is the male equivalent of HRT, and it's indicated for men with clinically low testosterone confirmed by blood tests. Symptoms include fatigue, low libido, mood changes, reduced muscle mass, and cognitive fog. TRT is available in injectable, gel, cream, and other forms. It requires baseline labs and ongoing monitoring to manage side effects like elevated hematocrit and ensure appropriate dosing.

Does HRT cause weight gain?

This is one of the most common concerns, and the research doesn't support it. HRT doesn't cause weight gain and may actually help prevent the metabolic changes that drive weight gain during menopause. Some women notice initial water retention when starting therapy, which typically resolves. Estrogen therapy can help maintain insulin sensitivity and body composition during the menopausal transition, particularly when combined with strength training and adequate protein intake.

At what age should I stop HRT?

There's no universal age cutoff. Current guidelines don't support a mandatory stop date for women who are still benefiting from HRT and have no contraindications. The risks of continuing therapy need to be weighed against the ongoing benefits, including bone protection and quality of life, on an individual basis. This decision should be made with a clinician who can review your current health status, not based on a general recommendation.

Citations
  1. Manson JE, Chlebowski RT, Stefanick ML, et al. Menopausal hormone therapy and health outcomes during the intervention and extended poststopping phases of the Women's Health Initiative randomized trials. JAMA. 2013;310(13):1353-1368. https://doi.org/10.1001/jama.2013.278040
  2. Boardman HM, Hartley L, Eisinga A, et al. Hormone therapy for preventing cardiovascular disease in post-menopausal women. Cochrane Database Syst Rev. 2015;(3):CD002229. https://doi.org/10.1002/14651858.CD002229.pub4
  3. Vinogradova Y, Coupland C, Hippisley-Cox J. Use of hormone replacement therapy and risk of venous thromboembolism: nested case-control studies using the QResearch and CPRD databases. BMJ. 2019;364:k4810. https://doi.org/10.1136/bmj.k4810
  4. Collaborative Group on Hormonal Factors in Breast Cancer. Type and timing of menopausal hormone therapy and breast cancer risk: individual participant meta-analysis of the worldwide epidemiological evidence. Lancet. 2019;394(10204):1159-1168. https://doi.org/10.1016/S0140-6736(19)31709-X
  5. Canonico M, Oger E, Plu-Bureau G, et al. Hormone therapy and venous thromboembolism among postmenopausal women: impact of the route of estrogen administration and progestogens. Circulation. 2007;115(7):840-845. https://doi.org/10.1161/CIRCULATIONAHA.106.642280
  6. Baber RJ, Panay N, Fenton A; IMS Writing Group. 2016 IMS Recommendations on women's midlife health and menopause hormone therapy. Climacteric. 2016;19(2):109-150. https://doi.org/10.3109/13697137.2015.1129166
  7. Bhasin S, Cunningham GR, Hayes FJ, et al. Testosterone therapy in men with androgen deficiency syndromes: an Endocrine Society clinical practice guideline. J Clin Endocrinol Metab. 2010;95(6):2536-2559. https://doi.org/10.1210/jc.2009-2354
  8. Lincoff AM, Bhasin S, Flevaris P, et al. Cardiovascular safety of testosterone-replacement therapy. N Engl J Med. 2023;389(2):107-117. https://doi.org/10.1056/NEJMoa2215025
  9. Lobo RA, Pickar JH, Stevenson JC, Mack WJ, Hodis HN. Back to the future: hormone replacement therapy as part of a prevention strategy for women at the onset of menopause. Atherosclerosis. 2016;254:282-290. https://doi.org/10.1016/j.atherosclerosis.2016.10.005
  10. Stuenkel CA, Davis SR, Gompel A, et al. Treatment of symptoms of the menopause: an Endocrine Society Clinical Practice Guideline. J Clin Endocrinol Metab. 2015;100(11):3975-4011. https://doi.org/10.1210/jc.2015-2236